Techniques used for protein expression proteomics study include:
Who was awarded the Nobel Prize for determining the amino acid sequence of insulin?
At what level is Kit B (basic emergency obstetric care supplies/ASHA kit/immunization supplies) provided in the healthcare system?
Which study design is most effective for investigating rare adverse effects of a drug?
Which of the following procedures is not typically covered by the National Programme for Control of Blindness (NPCB) for reimbursement of surgery done by a non-governmental organization (NGO) eye hospital?
Solid waste contaminated with blood and body fluids is classified under which category according to Bio-Medical Waste Management Rules?
Which of the following statements about phase IV clinical trials is correct?
Prohibition of participation in torture by a doctor comes under:
What is the primary purpose of interventional studies in clinical research?
A patient presents with symptoms of hyperthyroidism. Thyroid function tests would probably reveal:
Explanation: ***All of the options*** - All listed techniques—**Polyacrylamide Gel Electrophoresis (PAGE)**, **Gene Expression Analysis**, and **Mass Spectrometry**—are used in protein expression proteomics studies, either directly or indirectly, to analyze and quantify proteins. - The integration of these various techniques provides a comprehensive approach to understanding protein expression profiles. *PolyAcrylamide Gel Electrophoresis (PAGE)* - **PAGE** (including 1D and 2D-PAGE) is a fundamental technique for separating proteins based on their **molecular weight** and **isoelectric point**, which is crucial for visualizing and quantifying expressed proteins. - It often serves as an initial separation step before more detailed analysis, such as **mass spectrometry**. *Gene Expression Analysis (indirectly related to proteomics)* - Although **gene expression analysis** (e.g., using **RT-PCR** or **microarrays**) measures mRNA levels, it is indirectly related to proteomics because mRNA levels often **correlate with protein levels**. - It provides insights into the **transcriptional regulation** that influences protein expression, complementing direct protein analysis. *Mass Spectrometry* - **Mass spectrometry** is a powerful and widely used technique in proteomics for **identifying, quantifying, and characterizing proteins** and peptides by measuring their **mass-to-charge ratio**. - It can be used for both **discovery proteomics** (identifying novel proteins) and **targeted proteomics** (quantifying specific proteins).
Explanation: ***Sanger*** - **Frederick Sanger** was awarded the Nobel Prize in Chemistry in 1958 for his work on the **structure of proteins**, specifically for determining the **amino acid sequence of insulin**. - His method involved breaking down the protein into smaller fragments and then sequencing these fragments to reconstruct the entire protein structure. *Banting & Macleod* - **Frederick Banting** and **John Macleod** received the Nobel Prize in Physiology or Medicine in 1923 for the **discovery of insulin** itself. - Their work focused on isolating and demonstrating the therapeutic effects of insulin in treating diabetes. *Paul Berg* - **Paul Berg** was awarded the Nobel Prize in Chemistry in 1980 for his fundamental studies of the **biochemistry of nucleic acids**, particularly for his work on **recombinant DNA technology**. - His contributions were pivotal in the development of genetic engineering. *Charles Best* - **Charles Best** was a medical scientist who assisted Frederick Banting in the **discovery of insulin**. - While central to the discovery, he was not included in the Nobel Prize awarded to Banting and Macleod, though Banting shared his prize money with Best.
Explanation: ***Sub-center*** - **Kit B** is designed for use at the **Sub-center level** within the Indian healthcare system, specifically for **ASHA workers** and other grassroots healthcare providers. - It contains essential supplies for **basic emergency obstetric care**, as well as items for **immunization** and other primary healthcare needs in the community. *PHC* - **Primary Healthcare Centers (PHCs)** are a higher level of care compared to sub-centers and typically have more extensive facilities and a wider range of services. - While PHCs do offer obstetric care and immunization, **Kit B** itself is primarily intended for the more peripheral sub-center operations. *CHC* - **Community Healthcare Centers (CHCs)** serve as referral units for 4-5 PHCs and provide specialist services, including basic surgical and obstetric care. - The level of care and supplies at a CHC is far more comprehensive than what is contained in **Kit B**, which targets basic community-level interventions. *FRU level* - **First Referral Units (FRUs)** are typically equipped to handle all obstetric emergencies, including Caesarean sections and blood transfusions. - The scope of services at an FRU is significantly advanced, requiring a much broader inventory of medical supplies and equipment than what is found in **Kit B**.
Explanation: ***Case-control study*** - This design starts by identifying individuals with the **rare adverse effect (cases)** and a control group without the effect to look back for exposure to the drug. - It is efficient for studying rare outcomes because it doesn't require following a large population for a long time to observe few events. *Cohort study* - A **cohort study** follows a group of individuals exposed and unexposed to a drug forward in time to observe outcomes. - While good for common outcomes, it would require an **extremely large sample size** and a long follow-up period to observe rare adverse drug effects. *Cross-sectional study* - A **cross-sectional study** assesses exposure and outcome simultaneously at a single point in time. - This design is suitable for determining **prevalence** but cannot establish temporal relationships between drug exposure and rare adverse effects, nor is it efficient for rare outcomes. *Clinical trial/experimental study* - **Clinical trials** are primarily designed to test the efficacy and safety of new interventions, usually focusing on common adverse effects. - They are generally **not powered** or long enough to detect rare adverse events, as such events would occur in very few participants, if any.
Explanation: ***Syringing and probing of the nasolacrimal duct*** - While important for lacrimal drainage issues, procedures like **syringing and probing** are generally considered minor and less vision-restoring compared to the major surgeries targeted by the **NPCB**. - The **NPCB** focuses on interventions for leading causes of blindness, primarily **cataract** and other significant vision-threatening conditions, which this procedure typically isn't. *Cataract surgery* - **Cataract surgery** is a cornerstone of the **NPCB's** efforts, as cataracts are the leading cause of reversible blindness. - Reimbursement for **cataract surgery** is a primary objective to improve access and reduce the burden of blindness. *Pan retinal photocoagulation for diabetic retinopathy* - **Diabetic retinopathy** is a major cause of preventable blindness, and **pan retinal photocoagulation (PRP)** is a key intervention to preserve vision. - The **NPCB** includes procedures for **diabetic retinopathy** management due to its significant public health impact. *Trabeculectomy surgery* - **Trabeculectomy** is a surgical procedure for **glaucoma**, which is another significant cause of irreversible blindness. - The **NPCB** includes interventions for **glaucoma** given its severe vision-threatening nature and the need for surgical management in many cases.
Explanation: ***Correct: Category 6*** - According to the **Bio-Medical Waste Management Rules, 2016**, solid waste contaminated with blood and body fluids is categorized under **Category 6**. - This includes items like **dressings, plaster casts, cotton swabs, and bags containing residual or discarded blood and blood components**. - These items require specific handling and disposal methods as they pose infection risk due to visible soiling or soaking with blood and bodily fluids. *Incorrect: Category 9* - Category 9 refers to **discarded linen, mattresses, and beddings contaminated with blood or body fluids**. - While also dealing with blood-contaminated materials, this category is specifically for textile/fabric items, not general solid waste like dressings and swabs. *Incorrect: Category 5* - Category 5 covers **discarded medicines and cytotoxic drugs**, including expired, discarded, or contaminated pharmaceutical products. - This category deals with pharmaceutical waste, not materials contaminated with blood and body fluids. *Incorrect: Category 3* - Category 3 is designated for **microbiology, biotechnology, and other clinical laboratory waste**, including laboratory cultures, stocks or specimens of microorganisms, live or attenuated vaccines, and human and animal cell cultures. - This category focuses on infectious biological agents and laboratory waste, not general solid waste contaminated with blood and body fluids.
Explanation: ***It involves monitoring the long-term effects and safety of drugs.*** - **Phase IV clinical trials** are conducted **after a drug has been approved and marketed** to monitor its performance in the general population. - The primary goals include assessing the **long-term safety profile**, identifying rare adverse effects, and evaluating effectiveness under real-world conditions. *It is primarily focused on the efficacy of the drug.* - The primary focus on **drug efficacy** is typically addressed in **Phase II and Phase III clinical trials**, where controlled studies evaluate if the drug works as intended. - While efficacy is re-evaluated in real-world settings during Phase IV, it's not the primary or exclusive focus, which broadens to safety and comparative effectiveness. *It is conducted before a drug is submitted for approval.* - Trials conducted **before drug submission for approval** are typically **Phase I, Phase II, and Phase III clinical trials**, which are designed to establish safety, dosage, and initial efficacy. - **Phase IV trials** specifically begin **after a drug has received regulatory approval** and is available to the public. *It focuses primarily on determining the optimal dosage for patients.* - **Optimal dosage determination** is largely the domain of **Phase I and Phase II clinical trials**, where escalating doses are tested in small groups to identify a safe and effective range. - Phase IV studies might explore different dosing regimens in specific patient populations, but they do not primarily determine initial optimal dosing.
Explanation: ***Declaration of Tokyo*** - The **Declaration of Tokyo (1975)** specifically addresses the **prohibition of participation by doctors in torture** and other cruel, inhuman, or degrading treatment. - It mandates that physicians must not condone, facilitate, or participate in any form of torture, even under threat or duress. *Declaration of Helsinki* - This declaration focuses primarily on **ethical principles for medical research involving human subjects**. - It sets guidelines for **informed consent**, risk-benefit assessment, and the protection of vulnerable populations in research. *Declaration of Oslo* - The Declaration of Oslo (1970) deals with **therapeutic abortion** and the ethical considerations surrounding it. - It provides guidance on the physician's role and responsibilities when considering termination of pregnancy. *Declaration of Geneva* - Often referred to as a modern Hippocratic Oath, the Declaration of Geneva (1948) outlines the **general ethical duties of physicians**. - It emphasizes core principles such as respect for human life, professional secrecy, and beneficence, but does not specifically detail prohibitions regarding torture.
Explanation: ***Testing Hypotheses*** - Interventional studies, such as **randomized controlled trials**, are specifically designed to **test cause-and-effect relationships** by actively intervening. - They aim to determine if a specific intervention (e.g., a drug, a therapy) produces a hypothesized outcome. *Confirming Hypotheses* - While interventional studies can confirm hypotheses, their primary role is not just confirmation but the initial **rigorous testing** of a hypothesis under controlled conditions. - Confirmation often implies that previous evidence already strongly supports the hypothesis. *Manipulating Hypotheses* - Hypotheses themselves are not "manipulated"; rather, the **variables** within the study design (e.g., treatment groups, dosages) are manipulated to test the hypothesis. - This option incorrectly applies the concept of manipulation to the hypothesis. *Formulating Hypotheses* - Hypothesis formulation usually occurs during the **observational research phase** or through literature review, *before* interventional studies are designed. - Observational studies or descriptive research are more typically used for generating new hypotheses.
Explanation: ***Increased T4, Increased T3, decreased TSH*** - In **primary hyperthyroidism**, the thyroid gland overproduces thyroid hormones (**T3 and T4**), leading to elevated levels [1]. - The high levels of T3 and T4 then **feedback negatively** on the pituitary gland, suppressing the release of **TSH** [1]. *Increased T4, normal T3, and increased TSH* - This pattern is inconsistent with primary hyperthyroidism, as elevated T3 and T4 should suppress TSH. - An isolated increase in T4 with normal T3 can occur in **subclinical hyperthyroidism** or **thyroxine (T4) resistance**, but increased TSH would suggest pituitary dysfunction or resistance to thyroid hormones. *Increased T3, T4, and increased TSH* - Elevated T3 and T4 accompanied by **increased TSH** is a rare presentation, usually indicating **TSH-secreting pituitary adenoma** (secondary hyperthyroidism) or **thyroid hormone resistance** [1], [2]. - In typical hyperthyroidism, high thyroid hormone levels would suppress TSH. *Decreased T3 and T4, increased TSH* - This profile is characteristic of **primary hypothyroidism**, where an underactive thyroid gland produces insufficient T3 and T4 [1]. - The low thyroid hormone levels stimulate the pituitary to release **more TSH** in an attempt to stimulate thyroid hormone production [1].
Get full access to all questions, explanations, and performance tracking.
Start For Free